NASDAQ:NXL Nexalin Technology (NXL) Stock Price, News & Analysis $1.48 -0.01 (-0.67%) Closing price 11/13/2026 03:59 PM EasternExtended Trading$1.49 +0.01 (+0.61%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Nexalin Technology Stock (NASDAQ:NXL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nexalin Technology alerts:Sign Up Key Stats Today's Range$1.35▼$1.5850-Day Range$1.40▼$7.5552-Week Range$1.31▼$35.53Volume16,514 shsAverage Volume43,064 shsMarket Capitalization$1.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Nexalin Technology, Inc. (NASDAQ:NXL) is a medical technology company focused on developing and commercializing noninvasive neurostimulation devices for mental health and neurological applications. Its technology is designed to deliver low-intensity electrical stimulation to the brain with the goal of influencing neural activity associated with conditions such as depression, anxiety, insomnia, post-traumatic stress disorder and substance-use disorders. The company’s product portfolio includes the Gen-2 and Gen-3 neurostimulation systems. These devices use Nexalin’s proprietary waveform and transcranial electrical stimulation technology. The Gen-2 system has received regulatory clearance for certain uses, while the company continues to develop and evaluate newer-generation systems and additional clinical applications. Nexalin was founded in 2003 and is headquartered in Houston, Texas. The company serves healthcare providers and other potential institutional customers and has pursued commercial and distribution opportunities in international markets. Its products are intended to provide a noninvasive alternative or complement to conventional approaches for addressing symptoms related to mental health and brain-function disorders.AI Generated. May Contain Errors. Read More Nexalin Technology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreNXL MarketRank™: 0.94037299711 of 5 starsNexalin Technology scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingReduce Consensus RatingNexalin Technology has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageNexalin Technology has only been the subject of 2 research reports in the past 90 days.Read more about Nexalin Technology's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nexalin Technology are expected to grow in the coming year, from ($11.42) to ($7.55) per share.Price to Book Value per Share RatioNexalin Technology has a P/B Ratio of 0.25. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.06% of the float of Nexalin Technology has been sold short.Short Interest Ratio / Days to CoverNexalin Technology has a short interest ratio ("days to cover") of 0.21, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nexalin Technology has recently increased by 180.70%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNexalin Technology does not currently pay a dividend.Dividend GrowthNexalin Technology does not have a long track record of dividend growth. News and Social Media1.7 / 5News Sentiment-0.30 News SentimentNexalin Technology has a news sentiment score of -0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Nexalin Technology this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added Nexalin Technology to their MarketBeat watchlist in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nexalin Technology insiders have not sold or bought any company stock.Percentage Held by Insiders16.94% of the stock of Nexalin Technology is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.65% of the stock of Nexalin Technology is held by institutions.Read more about Nexalin Technology's insider trading history. Receive NXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NXL Stock News HeadlinesNexalin Technology, Inc. (NASDAQ:NXL) Stock Short Interest Jumps 180.7%November 13 at 4:03 AM | americanbankingnews.comNexalin Technology (NXL) Set to Release Quarterly Earnings on FridayNovember 6, 2026 | americanbankingnews.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 14 at 1:00 AM | Behind the Markets (Ad)Nexalin’s HALO Clarity™ Insomnia Trial Moves Toward Launch: What Investors Need to KnowOctober 30, 2026 | tipranks.comNXL - Nexalin Technology, Inc.October 28, 2026 | seekingalpha.comNexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's DiseaseOctober 27, 2026 | globenewswire.comNuix Launches Agentic AI in Nuix Neo with Audit Trail Built InOctober 21, 2026 | prnewswire.comNexalin Technology Regains Compliance With Nasdaq Minimum Bid Price Requirement; Stock DownOctober 8, 2026 | rttnews.comSee More Headlines NXL Stock Analysis - Frequently Asked Questions How have NXL shares performed this year? Nexalin Technology's stock was trading at $16.74 at the beginning of 2026. Since then, NXL shares have decreased by 91.2% and is now trading at $1.48. How were Nexalin Technology's earnings last quarter? Nexalin Technology, Inc. (NASDAQ:NXL) announced its quarterly earnings data on Thursday, November, 12th. The company reported ($3.43) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.91) by $0.52. The business had revenue of $78.30 thousand for the quarter, compared to analysts' expectations of $75 thousand. Nexalin Technology had a negative net margin of 3,384.12% and a negative trailing twelve-month return on equity of 344.93%. When did Nexalin Technology's stock split? Nexalin Technology's stock reverse split before market open on Monday, August 31st 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, August 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Nexalin Technology IPO? Nexalin Technology (NXL) raised $14 million in an initial public offering (IPO) on Friday, September 16th 2022. The company issued 2,315,000 shares at a price of $5.00-$7.00 per share. How do I buy shares of Nexalin Technology? Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nexalin Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nexalin Technology investors own include Intel (INTC), SoundHound AI (SOUN), IonQ (IONQ), UiPath (PATH), Micron Technology (MU), NVIDIA (NVDA) and Palantir Technologies (PLTR). Company Calendar Last Earnings11/12/2026Today11/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NXL's financial health is in the Red zone, according to TradeSmith. NXL has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NXL CIK1527352 Webwww.nexalin.com Phone832-260-0222FaxN/AEmployees8Year FoundedN/AProfitability EPS (Trailing Twelve Months)($14.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$8.22 million Net Margins-3,384.12% Pretax Margin-4,142.40% Return on Equity-344.93% Return on Assets-248.12% Debt Debt-to-Equity RatioN/A Current Ratio1.25 Quick Ratio1.10 Sales & Book Value Annual Sales$300 thousand Price / Sales3.60 Cash FlowN/A Price / Cash FlowN/A Book Value$6.03 per share Price / Book0.25Miscellaneous Outstanding Shares730,000Free Float610,000Market Cap$1.08 million OptionableNot Optionable Beta4.31 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:NXL) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredLog into Keith’s $5,000 AI Signals Trading system todayA new AI system from the TradeSmith Daily team shows trades taking shape 90 minutes before they occur, with 93...TradeSmith | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
